Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Swiss Exchange  -  11:30 2022-12-07 am EST
85.78 CHF   +0.59%
12:07pGlobal markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
12/06Novartis' Combination Breast Cancer Therapy Boosts Progression-free Survival in Mid-sta..
MT
12/06Novartis Says Kisqali Results in Better Progression-Free Survival Than Chemotherapy in ..
MT
12/06Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggre..
GL
12/06Novartis Kisqali(R) prolonged PFS benefit for pre- and perimenopausal patients with agg..
DJ
12/06NOVARTIS AG : UBS reiterates its Neutral rating
MD
12/06BNP Paribas Lowers Price Target on Novartis, Maintains Neutral Recommendation
MT
12/06Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
12/05Stifel Upgrades Recommendation on Novartis to Buy From Hold
MT
12/05Novartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
12/05Novartis' Prostate Cancer Drug Extends Progression-free Survival In Late-stage Study
MT
12/05Novartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
12/05Novartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
DJ
12/05Novartis AG Pluvicto Shows Statistically Significant and Clinically Meaningful Radiogra..
CI
More most relevant news
All news about NOVARTIS AG
12:07pGlobal markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
12/06Novartis Signs Licensing Deal for MorphoSys Unit's Cancer Program
MT
12/06Novartis' Combination Breast Cancer Therapy Boosts Progression-free Survival in Mid-sta..
MT
12/06Novartis Says Kisqali Results in Better Progression-Free Survival Than Chemotherapy in ..
MT
12/06Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggre..
GL
12/06Novartis Kisqali(R) prolonged PFS benefit for pre- and perimenopausal patients with agg..
DJ
12/06NOVARTIS AG : UBS reiterates its Neutral rating
MD
12/06BNP Paribas Lowers Price Target on Novartis, Maintains Neutral Recommendation
MT
More news
News in other languages on NOVARTIS AG
12:23pLATE BRIEFING - Unternehmen und Märkte
12:16pAktien Schweiz Schluss: SMI schliesst knapp über 11'000er Marke
12:15pBourse Zurich: le SMI faiblit sur des perspectives moroses
12:06pMÄRKTE EUROPA/Leichter - Kursgewinne bei Pharmaaktien
12:05pAktien Frankfurt Schluss: Schwacher Wochenverlauf geht weiter
11:50aXETRA-SCHLUSS/Leichter - Airbus geben nach
11:43aBorsa svizzera: chiude in ribasso, SMI -0,89%
11:43aAktien Schweiz schließen schwächer - Lonza erneut unter Druck
10:10aWdh/Aktien Frankfurt: Dax gibt weiter nach - 'Positive Aspekte ausg..
09:49aMÄRKTE EUROPA/Knapp behauptet - Airbus unter Druck
More news
Analyst Recommendations on NOVARTIS AG
06:09aNOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
12/06NOVARTIS AG : UBS reiterates its Neutral rating
MD
12/06BNP Paribas Lowers Price Target on Novartis, Maintains Neutral Recommendation
MT
12/06Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
12/05Stifel Upgrades Recommendation on Novartis to Buy From Hold
MT
More recommendations
Press releases
09:55aMorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
12/06Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggre..
GL
12/05Novartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
12/01European Court Of Justice Issues Lan : No Repackaging/Rebranding As The Originator Referen..
AQ
11/24Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study f..
AQ
More press releases
Analysis
Novartis earnings slip 4% on strong dollar, Gilenya competition
Stock Pick
 NOVARTIS AG
Back to basics
Stock Trading Strategies
TRADING
 Comeback of a rising trend?
Upcoming event on NOVARTIS AG
12/06/22San antonio breast cancer symposium - abstract number : #gs1-10
Upcoming sector events
01/24/23JOHNSON & JOHNSON : FY 2022 Earnings Release
01/27/23ABBVIE INC. : FY 2022 Earnings Release (Projected)
01/31/23PFIZER INC. : FY 2022 Earnings Release (Projected)
02/01/23NOVO NORDISK A/S : FY 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals